Preirradiation chemotherapy for very young children with brain tumors

Mei Jy Jeng, Te Kau Chang, Tai-Tong Wong, Yuh Lin Hsien, Ran Bin Tang, Betau Hwang

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Standard management of malignant brain tumors includes either surgical resection alone or surgery followed by irradiation. However, neuroaxis irradiation administered to very young children for primary intracranial tumors is often associated with major late side effects. To delay irradiation and evaluate the efficacy of preirradiation chemotherapy, we treated 9 young children (aged less than 3 years), who had newly diagnosed brain tumors and underwent total or subtotal resection, with a combination of chemotherapy including vinblastine, cisplatin, and etoposide every 3-4 weeks for 6-14 courses between 1988 and 1992. There were malignat gliomas in four patients, medulloblastomas in three, and ependymomas in two. A response to preirradiation chemotherapy (complete remission or partial remission) occurred in seven out of nine cases. Only one patient had progressive disease during the chemotherapy period. Preirradiation chemotherapy with vinblastine, cisplatin, and etoposide might be a highly effective combination allowing delay of radiation therapy in very young children with brain tumors. Acute and subacute toxicity of chemotherapy in this study was mild.

Original languageEnglish
Pages (from-to)150-153
Number of pages4
JournalChild's Nervous System
Volume9
Issue number3
DOIs
Publication statusPublished - Jun 1 1993
Externally publishedYes

Fingerprint

Brain Neoplasms
Drug Therapy
Vinblastine
Etoposide
Cisplatin
Ependymoma
Medulloblastoma
Combination Drug Therapy
Glioma
Radiotherapy
Neoplasms

Keywords

  • Brain tumor
  • Chemotherapy
  • Neuroaxis radiation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Clinical Neurology

Cite this

Jeng, M. J., Chang, T. K., Wong, T-T., Hsien, Y. L., Tang, R. B., & Hwang, B. (1993). Preirradiation chemotherapy for very young children with brain tumors. Child's Nervous System, 9(3), 150-153. https://doi.org/10.1007/BF00272265

Preirradiation chemotherapy for very young children with brain tumors. / Jeng, Mei Jy; Chang, Te Kau; Wong, Tai-Tong; Hsien, Yuh Lin; Tang, Ran Bin; Hwang, Betau.

In: Child's Nervous System, Vol. 9, No. 3, 01.06.1993, p. 150-153.

Research output: Contribution to journalArticle

Jeng, MJ, Chang, TK, Wong, T-T, Hsien, YL, Tang, RB & Hwang, B 1993, 'Preirradiation chemotherapy for very young children with brain tumors', Child's Nervous System, vol. 9, no. 3, pp. 150-153. https://doi.org/10.1007/BF00272265
Jeng, Mei Jy ; Chang, Te Kau ; Wong, Tai-Tong ; Hsien, Yuh Lin ; Tang, Ran Bin ; Hwang, Betau. / Preirradiation chemotherapy for very young children with brain tumors. In: Child's Nervous System. 1993 ; Vol. 9, No. 3. pp. 150-153.
@article{9800d121d9d94884bd221bb2d393eb93,
title = "Preirradiation chemotherapy for very young children with brain tumors",
abstract = "Standard management of malignant brain tumors includes either surgical resection alone or surgery followed by irradiation. However, neuroaxis irradiation administered to very young children for primary intracranial tumors is often associated with major late side effects. To delay irradiation and evaluate the efficacy of preirradiation chemotherapy, we treated 9 young children (aged less than 3 years), who had newly diagnosed brain tumors and underwent total or subtotal resection, with a combination of chemotherapy including vinblastine, cisplatin, and etoposide every 3-4 weeks for 6-14 courses between 1988 and 1992. There were malignat gliomas in four patients, medulloblastomas in three, and ependymomas in two. A response to preirradiation chemotherapy (complete remission or partial remission) occurred in seven out of nine cases. Only one patient had progressive disease during the chemotherapy period. Preirradiation chemotherapy with vinblastine, cisplatin, and etoposide might be a highly effective combination allowing delay of radiation therapy in very young children with brain tumors. Acute and subacute toxicity of chemotherapy in this study was mild.",
keywords = "Brain tumor, Chemotherapy, Neuroaxis radiation",
author = "Jeng, {Mei Jy} and Chang, {Te Kau} and Tai-Tong Wong and Hsien, {Yuh Lin} and Tang, {Ran Bin} and Betau Hwang",
year = "1993",
month = "6",
day = "1",
doi = "10.1007/BF00272265",
language = "English",
volume = "9",
pages = "150--153",
journal = "Child's Nervous System",
issn = "0256-7040",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Preirradiation chemotherapy for very young children with brain tumors

AU - Jeng, Mei Jy

AU - Chang, Te Kau

AU - Wong, Tai-Tong

AU - Hsien, Yuh Lin

AU - Tang, Ran Bin

AU - Hwang, Betau

PY - 1993/6/1

Y1 - 1993/6/1

N2 - Standard management of malignant brain tumors includes either surgical resection alone or surgery followed by irradiation. However, neuroaxis irradiation administered to very young children for primary intracranial tumors is often associated with major late side effects. To delay irradiation and evaluate the efficacy of preirradiation chemotherapy, we treated 9 young children (aged less than 3 years), who had newly diagnosed brain tumors and underwent total or subtotal resection, with a combination of chemotherapy including vinblastine, cisplatin, and etoposide every 3-4 weeks for 6-14 courses between 1988 and 1992. There were malignat gliomas in four patients, medulloblastomas in three, and ependymomas in two. A response to preirradiation chemotherapy (complete remission or partial remission) occurred in seven out of nine cases. Only one patient had progressive disease during the chemotherapy period. Preirradiation chemotherapy with vinblastine, cisplatin, and etoposide might be a highly effective combination allowing delay of radiation therapy in very young children with brain tumors. Acute and subacute toxicity of chemotherapy in this study was mild.

AB - Standard management of malignant brain tumors includes either surgical resection alone or surgery followed by irradiation. However, neuroaxis irradiation administered to very young children for primary intracranial tumors is often associated with major late side effects. To delay irradiation and evaluate the efficacy of preirradiation chemotherapy, we treated 9 young children (aged less than 3 years), who had newly diagnosed brain tumors and underwent total or subtotal resection, with a combination of chemotherapy including vinblastine, cisplatin, and etoposide every 3-4 weeks for 6-14 courses between 1988 and 1992. There were malignat gliomas in four patients, medulloblastomas in three, and ependymomas in two. A response to preirradiation chemotherapy (complete remission or partial remission) occurred in seven out of nine cases. Only one patient had progressive disease during the chemotherapy period. Preirradiation chemotherapy with vinblastine, cisplatin, and etoposide might be a highly effective combination allowing delay of radiation therapy in very young children with brain tumors. Acute and subacute toxicity of chemotherapy in this study was mild.

KW - Brain tumor

KW - Chemotherapy

KW - Neuroaxis radiation

UR - http://www.scopus.com/inward/record.url?scp=0027304923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027304923&partnerID=8YFLogxK

U2 - 10.1007/BF00272265

DO - 10.1007/BF00272265

M3 - Article

VL - 9

SP - 150

EP - 153

JO - Child's Nervous System

JF - Child's Nervous System

SN - 0256-7040

IS - 3

ER -